Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL

Summary

The purpose of this multi-center, single arm, phase Ⅱ clinical trail is to evaluate the efficacy and toxicity of concurrent chemoradiotherapy by using single-drug pegaspargase for patients with ENKTL in stage IE to IIE.

Timeline

Start

2016-03-01

Primary completion

2026-03-01

Completion

2026-03-01

Drugs

Indications